Peter A. Csurhes

2.1k total citations
39 papers, 1.2k citations indexed

About

Peter A. Csurhes is a scholar working on Pathology and Forensic Medicine, Immunology and Oncology. According to data from OpenAlex, Peter A. Csurhes has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 17 papers in Immunology and 13 papers in Oncology. Recurrent topics in Peter A. Csurhes's work include Multiple Sclerosis Research Studies (18 papers), Peripheral Neuropathies and Disorders (9 papers) and Polyomavirus and related diseases (7 papers). Peter A. Csurhes is often cited by papers focused on Multiple Sclerosis Research Studies (18 papers), Peripheral Neuropathies and Disorders (9 papers) and Polyomavirus and related diseases (7 papers). Peter A. Csurhes collaborates with scholars based in Australia, New Zealand and Switzerland. Peter A. Csurhes's co-authors include Michael P. Pender, Pamela McCombe, Scott R. Burrows, Judith M. Greer, Casey MM Pfluger, Jacqueline M. Burrows, C M Rzepczyk, Alan Coulthard, Michael F. Good and Stefan Blum and has published in prestigious journals such as Blood, The Journal of Immunology and Brain Research.

In The Last Decade

Peter A. Csurhes

38 papers receiving 1.1k citations

Peers

Peter A. Csurhes
Foroozan Mokhtarian United States
Ying C. Q. Zang United States
W. Lüer Germany
Dun Zhou Germany
V. Navikas Sweden
E. J. Thompson United Kingdom
M. Pette Germany
Peter A. Csurhes
Citations per year, relative to Peter A. Csurhes Peter A. Csurhes (= 1×) peers David Brassat

Countries citing papers authored by Peter A. Csurhes

Since Specialization
Citations

This map shows the geographic impact of Peter A. Csurhes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Csurhes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Csurhes more than expected).

Fields of papers citing papers by Peter A. Csurhes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. Csurhes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Csurhes. The network helps show where Peter A. Csurhes may publish in the future.

Co-authorship network of co-authors of Peter A. Csurhes

This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. Csurhes. A scholar is included among the top collaborators of Peter A. Csurhes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. Csurhes. Peter A. Csurhes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ioannides, Zara A., Peter A. Csurhes, Andrew Swayne, et al.. (2021). Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein–Barr Virus-Specific T Cell Therapy. Frontiers in Neurology. 12. 652811–652811. 25 indexed citations
2.
Pender, Michael P., Peter A. Csurhes, Corey Smith, et al.. (2018). Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis. JCI Insight. 3(22). 110 indexed citations
3.
Pender, Michael P., Peter A. Csurhes, Jacqueline M. Burrows, & Scott R. Burrows. (2017). Defective T‐cell control of Epstein–Barr virus infection in multiple sclerosis. Clinical & Translational Immunology. 6(1). 100 indexed citations
4.
Pender, Michael P., Peter A. Csurhes, & Scott R. Burrows. (2015). Impaired T cell control of Epstein-Barr virus infection in multiple sclerosis. Multiple Sclerosis Journal. 21(14). 1 indexed citations
6.
Blum, Stefan, et al.. (2013). Killer immunoglobulin-like receptor and their HLA ligands in Guillain–Barré Syndrome. Journal of Neuroimmunology. 267(1-2). 92–96. 22 indexed citations
7.
McCombe, Pamela & Peter A. Csurhes. (2010). T cells from patients with Guillain-Barré syndrome produce interferon-gamma in response to stimulation with the ganglioside GM1. Journal of Clinical Neuroscience. 17(4). 537–538. 9 indexed citations
8.
Greer, Judith M., et al.. (2008). Correlation of Blood T Cell and Antibody Reactivity to Myelin Proteins with HLA Type and Lesion Localization in Multiple Sclerosis. The Journal of Immunology. 180(9). 6402–6410. 35 indexed citations
10.
Csurhes, Peter A., et al.. (2006). Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy. Journal of Neurology Neurosurgery & Psychiatry. 78(4). 419–422. 41 indexed citations
11.
Tajouri, Lotti, Virginie Martin, Rod A. Lea, et al.. (2006). Genetic investigation of methylenetetrahydrofolate reductase (MTHFR) and catechol-O-methyl transferase (COMT) in multiple sclerosis. Brain Research Bulletin. 69(3). 327–331. 25 indexed citations
12.
Fowdar, Javed, Natalie Colson, Lotti Tajouri, et al.. (2006). No association between MTHFR A1298C and MTRR A66G polymorphisms, and MS in an Australian cohort. Journal of the Neurological Sciences. 252(1). 49–52. 3 indexed citations
13.
McCombe, Pamela, Peter A. Csurhes, & Judith M. Greer. (2006). Studies of HLA associations in male and female patients with Guillain–Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Journal of Neuroimmunology. 180(1-2). 172–177. 35 indexed citations
14.
McCombe, Pamela, et al.. (2005). HLA-DR2 is associated with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) in females, but not males. Clinical Immunology. 115. 1 indexed citations
15.
Tajouri, Lotti, Matthew P. Johnson, Lyn R. Griffiths, et al.. (2005). VARIATION IN THE VITAMIN D RECEPTOR GENE IS ASSOCIATED WITH MULTIPLE SCLEROSIS IN AN AUSTRALIAN POPULATION. Journal of Neurogenetics. 19(1). 25–38. 4 indexed citations
16.
Greer, Judith M., Peter A. Csurhes, Michael P. Pender, & Pamela McCombe. (2004). Effect of gender on T-cell proliferative responses to myelin proteolipid protein antigens in patients with multiple sclerosis and controls. Journal of Autoimmunity. 22(4). 345–352. 29 indexed citations
17.
Pender, Michael P., et al.. (2003). Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis. Journal of Clinical Neuroscience. 10(1). 63–66. 52 indexed citations
19.
Pender, Michael P., Peter A. Csurhes, Judith M. Greer, et al.. (2000). Surges of Increased T Cell Reactivity to an Encephalitogenic Region of Myelin Proteolipid Protein Occur More Often in Patients with Multiple Sclerosis Than in Healthy Subjects. The Journal of Immunology. 165(9). 5322–5331. 57 indexed citations
20.
Rzepczyk, C M, et al.. (1990). Synthetic peptide immunogens eliciting antibodies to Plasmodium falciparum sporozoite and merozoite surface antigens in H-2b and H-2k mice.. The Journal of Immunology. 145(8). 2691–2696. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026